Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$289K Sell
896
-20
-2% -$6.54K 0.03% 180
2024
Q2
$286K Sell
916
-475
-34% -$140K 0.03% 174
2024
Q1
$396K Buy
1,391
+203
+17% +$59.4K 0.05% 99
2023
Q4
$342K Buy
1,188
+6
+0.5% +$1.64K 0.07% 100
2023
Q3
$318K Buy
1,182
+21
+2% +$5.24K 0.08% 98
2023
Q2
$258K Buy
+1,161
New +$269K 0.07% 119
2021
Q1
Sell
-611
Closed -$155K 105
2020
Q4
$155K Buy
+611
New +$141K 0.13% 99

Other funds holding AMGN

Diversified's AMGN Position: Q3 2024 in Review

Diversified reduced its Amgen (AMGN) stake by 2.2% in Q3 2024, selling an estimated $6.54K and leaving 896 shares worth $289K. The position accounts for 0.03% of the portfolio, ranked #180.

Diversified first reported a position in AMGN in Q4 2020 and has held it in 7 quarters since. The position peaked at $396K in Q1 2024. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Diversified held 896 shares of Amgen worth $289K as of Q3 2024.
  • Diversified sold 20 Amgen shares in Q3 2024, an estimated $6.54K.
  • Amgen made up 0.03% of Diversified's portfolio in Q3 2024, its #180 holding.
  • Diversified first reported a position in Amgen in Q4 2020 and has held it in 7 quarters since.
  • Diversified's Amgen position peaked at $396K in Q1 2024.
  • 2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Diversified's 13F filing for Q3 2024, filed 13 Nov 2024.